Peter Powchik

CIK 1377247 · SVP Clinical Development & Reg · last filed 2023-10-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.77M

Companies

2

Total Filings

30

Lifetime Open-Market Net

-$40.97M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Vaxxinity, Inc. (VAXX) Delisted Director 225,858 $0.11 $25.1K $0 4 2023-10-11
REGN SVP Clinical Development & Reg 27,388 $612.14 $16.77M -$40.97M 26 2016-12-19

Recent Filings · Page 2 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-01-03 REGN Mixed -$11.75M EDGAR
2013-12-26 REGN Exer (M) +4,705 $100.0K EDGAR
2013-12-20 REGN Mixed −9,000 -$2.50M EDGAR
2013-12-17 REGN Mixed +9,000 -$2.62M EDGAR
2013-01-10 REGN Exer (M) +5,752 $100.0K EDGAR
2013-01-04 REGN Mixed -$4.76M EDGAR
2012-12-20 REGN Mixed -$5.57M EDGAR
2012-12-17 REGN Grant (A) $0 EDGAR
2012-11-09 REGN Sell (S) −15,144 -$2.10M EDGAR
2012-09-20 REGN Mixed -$1.97M EDGAR
Showing 1120 of 30
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.